Wahida Hassan

Wahida Hassan

Auto-generated profile, based on publicly available information

Wahida Hassan

Zanzibar Malaria Elimination Program (ZAMEP)

Research Focus & Metrics

Academic Career Length

2Years (2025-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
23 March 2025 in medRxiv
Verified
Preprint
Open access
PDF file
SCSean V. Connelly
Sean V. Connelly
JMJulia G. Muller
Julia G. Muller
MAMohamed Ali
Mohamed Ali
BNBilly Ngasala
Billy Ngasala
WHWahida Hassan
Wahida Hassan
JJJonathan J. Juliano
Jonathan J. Juliano
Artemisinin partial resistance (ART-R), driven by Plasmodium falciparum K13 mutations, threatens malaria control. Zanzibar is vulnerable to ART-R spread but lacks recent molecular surveillance. We sequenced samples in Zanzibar and mainland Tanzania collected in 2022-2024. K13 mutations (P441L, A675V) were found in 2/1440 Zanzibar participants and 6/3762 (R561H, P441L) in mainland Tanzania. K13 mutations appear to be of African origin and spreading regionally based on whole genome sequencing data. Frequent parasite importation appears to maintain partner drug mutation frequencies similar to the mainland, where artemether-lumefantrine selects for mutations favoring artesunate-amodiaquine sensitivity. Ongoing molecular surveillance remains essential to track these patterns. Summary K13 mutations linked to artemisinin resistance were uncommon in Zanzibar and mainland Tanzania in 2022–2024. Whole genome sequencing suggests an African origin with regional spread of mutations. Continued surveillance is critical to monitor evolving resistance and drug selection dynamics.

2 February 2026 in Open Forum Infectious Diseases
Verified
Journal Article
Open access
VGVarun Goel
Varun Goel
WHWahida Hassan
Wahida Hassan
CMCaroline Murphy
Caroline Murphy
BCBarbara B Choloi
Barbara B Choloi
MAMohamed Ali
Mohamed Ali
JLJessica T Lin
Jessica T Lin
Background: The Zanzibar archipelago has been a pre-elimination region for malaria thanks to rigorous control interventions, but recent surges in malaria cases have been observed. The contribution of non-falciparum species to the current malaria situation is unknown. Method: This study investigates the epidemiology of falciparum and non-falciparum malaria species in Zanzibar. Leveraging plasma extracted from dried blood spots (DBS) collected during reactive case detection (RCD) activities across Unguja island from May 2022 to January 2023, we measured immunoglobulin G (IgG) responses to Plasmodium MSP1-19kD antigens using a multiplex bead-based immunoassay. Additionally, active infections were detected using species-specific real-time PCR. Results: Out of 1618 participants surveyed in 35 RCDs, 35.3% had exposure to any malaria species, with Plasmodium falciparum being the most common (29.8%). Seroprevalences for non-falciparum species were lower: Plasmodium ovale (5.8%), Plasmodium malariae (5.9%), and Plasmodium vivax (5.9%). Active infections were detected in 6.0% of participants, predominantly P. falciparum (4.6%). Travel to mainland Tanzania was a dominant risk factor for seropositivity for all 4 malaria species. Other factors associated with Pf seropositivity (high-risk occupations and female status) were not associated with seropositivity for non-falciparum species. The geographic distribution of non-falciparum exposure differed compared to falciparum, with relatively higher seroprevalences in rural districts, especially Kazkazini A in northern Unguja. Conclusions: This study suggests a significant contribution of non-falciparum species to the local epidemiology in Zanzibar. Current control and elimination efforts, focused on P. falciparum, may not adequately address exposure to non-falciparum species.

21 May 2025 in medRxiv
Verified
Preprint
Open access
PDF file
VGVarun Goel
Varun Goel
WHWahida Hassan
Wahida Hassan
CMCaroline Murphy
Caroline Murphy
BCBarbara B. Choloi
Barbara B. Choloi
MAMohamed Ali
Mohamed Ali
JLJessica T. Lin
Jessica T. Lin
Background: The Zanzibar archipelago has been a pre-elimination region for malaria thanks to rigorous control interventions, but recent surges in malaria cases have been observed. The contribution of non-falciparum species to the current malaria situation is unknown. Methods: This study investigates the seroepidemiology of falciparum and non-falciparum malaria species in Zanzibar. Leveraging plasma extracted from dried blood spots (DBS) collected during reactive case detection (RCD) activities across Unguja island from May 2022 to May 2023, we measured immunoglobulin G (IgG) responses to Plasmodium MSP1-19kD antigens using a multiplex bead-based immunoassay. Additionally, active infections were detected using species-specific real-time PCR. Results: Out of 1,618 participants surveyed in 35 RCDs, 35.3% had exposure to any malaria species, with P. falciparum being the most common (29.8%). Seroprevalences for non-falciparum species were lower: P. ovale (5.8%), P. malariae (5.9%), and P. vivax (5.9%). Active infections were detected in 6.0% of participants, predominantly P. falciparum (4.6%). Travel to mainland Tanzania was a dominant risk factor for seropositivity for all four malaria species. Other factors associated with Pf seropositivity (high-risk occupations, female status) were not associated with seropositivity for non-falciparum species. The geographic distribution of non-falciparum exposure differed compared to falciparum, with relatively higher seroprevalences in rural districts, especially Kazkazini A in northern Unguja. Discussion: This study suggests a significant contribution of non-falciparum species to the local epidemiology in Zanzibar. Current control and elimination efforts, focused on P. falciparum , may not adequately address exposure to non-falciparum species.